Intermittent negative pressure ventilation in the treatment of respiratory failure in progressive neuromuscular disease

S. R. Braun*, R. L. Sufit, R. Giovannoni, M. O'Connor, H. Peters

*Corresponding author for this work

Research output: Contribution to journalArticle

13 Scopus citations

Abstract

Five men with degenerative neuromuscular diseases (three with amyotrophic lateral sclerosis [ALS] and two with Duchenne’s muscular dystrophy [DMD]) who had respiratory failure were treated with intermittent negative pressure ventilation (NPV). One patient with ALS in severe acute respiratory failure was successfully treated with NPV alone. This patient and two other ALS patients in chronic respiratory failure with Paco2 elevation stabilized or improved their vital capacity (VC) and lowered their Paco2 after 5 to 11 weeks of therapy. Finally, intermittent NPV was used to replace 24-hour positive pressure ventilation in two patients with DMD. It is concluded that intermittent NPV may stabilize or temporarily improve the respiratory status in patients with progressive neuromuscular diseases.

Original languageEnglish (US)
Pages (from-to)1874-1875
Number of pages2
JournalNeurology
Volume37
Issue number12
StatePublished - Dec 1987

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Intermittent negative pressure ventilation in the treatment of respiratory failure in progressive neuromuscular disease'. Together they form a unique fingerprint.

  • Cite this